APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 54 filers reported holding APTOSE BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $424,324 | +9.7% | 663,007 | -0.5% | 0.00% | – |
| Q4 2022 | $386,632 | -2.6% | 666,607 | 0.0% | 0.00% | – |
| Q3 2022 | $397,000 | -19.8% | 666,607 | 0.0% | 0.00% | – |
| Q2 2022 | $495,000 | -45.4% | 666,607 | 0.0% | 0.00% | – |
| Q1 2022 | $907,000 | +0.8% | 666,607 | 0.0% | 0.00% | – |
| Q4 2021 | $900,000 | -45.1% | 666,607 | -11.3% | 0.00% | – |
| Q3 2021 | $1,639,000 | -26.1% | 751,802 | +12.5% | 0.00% | – |
| Q2 2021 | $2,219,000 | -44.4% | 668,488 | +0.1% | 0.00% | -100.0% |
| Q1 2021 | $3,990,000 | +36.6% | 667,765 | +0.2% | 0.00% | 0.0% |
| Q4 2020 | $2,920,000 | -30.5% | 666,673 | -4.8% | 0.00% | 0.0% |
| Q3 2020 | $4,204,000 | -1.5% | 700,602 | +3.6% | 0.00% | 0.0% |
| Q2 2020 | $4,269,000 | +5.6% | 676,470 | -0.6% | 0.00% | 0.0% |
| Q1 2020 | $4,044,000 | +2427.5% | 680,767 | +2314.9% | 0.00% | – |
| Q4 2019 | $160,000 | – | 28,190 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 565,000 | $768,000 | 0.80% |
| SANDERS MORRIS HARRIS LLC | 2,342,694 | $3,186,000 | 0.62% |
| Nantahala Capital Management | 7,322,189 | $9,958,000 | 0.44% |
| DRW Securities, LLC | 8,892,437 | $12,094,000 | 0.33% |
| PRECEPT MANAGEMENT LLC | 227,000 | $309,000 | 0.33% |
| Voss Capital, LLC | 550,000 | $748,000 | 0.24% |
| CARLSON CAPITAL L P | 1,564,700 | $2,128,000 | 0.15% |
| Annandale Capital, LLC | 200,000 | $272,000 | 0.11% |
| Sigma Planning Corp | 791,274 | $1,076,000 | 0.03% |
| WealthShield Partners, LLC | 104,920 | $143,000 | 0.02% |